Skip to main content
Journal cover image

Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.

Publication ,  Journal Article
Vasquez, P; Escalante, J; Raghubar, KP; Kahalley, LS; Taylor, OA; Moore, IK; Hockenberry, MJ; Scheurer, ME; Brown, AL
Published in: Pediatric blood & cancer
May 2022

Survivors of pediatric acute lymphoblastic leukemia (ALL) are at increased risk of neurocognitive weakness in the areas of attention, executive function, and processing speed. Although fatigue and sleep disturbances are frequent complications of ALL therapy and associated with cognitive functions, the impact of fatigue and sleep profiles during active ALL treatment on posttreatment neurocognitive performance has received limited attention.Pediatric patients (n = 120) with ALL (diagnosed 2011-2016) who completed fatigue and sleep questionnaires at four time points during active treatment were enrolled in a study of neurocognitive performance. Latent class growth analysis identified subgroups of patients with similar sleep and fatigue profiles during treatment. Neurocognitive performance collected >6 months post treatment on 40 participants was compared between latent classes using multivariable linear regression models.Participants (57.5% male and 79.1% Hispanic or non-Hispanic White) were classified into one of two fatigue and sleep profiles: Class 1 characterized by mild fatigue and sleep disturbances during treatment (50.8%), and Class 2 characterized by higher levels of fatigue and sleep disturbances (49.2%). Posttreatment cognitive performance was in the normal range for most measures, but significantly below normative means for executive function, verbal short-term memory, attention, and distractability measures. Compared to Class 1, Class 2 demonstrated significantly (p < .05) poorer posttreatment neurocognitive performance, particularly in measures of attention.Our findings indicate that fatigue and sleep disturbances during the first year of pediatric ALL therapy may impact long-term neurocognitive performance. Sleep and fatigue may be targets for intervention to preserve cognitive functioning in survivors.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatric blood & cancer

DOI

EISSN

1545-5017

ISSN

1545-5009

Publication Date

May 2022

Volume

69

Issue

5

Start / End Page

e29507

Related Subject Headings

  • Sleep Wake Disorders
  • Sleep
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Oncology & Carcinogenesis
  • Neuropsychological Tests
  • Male
  • Humans
  • Female
  • Fatigue
  • Executive Function
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Vasquez, P., Escalante, J., Raghubar, K. P., Kahalley, L. S., Taylor, O. A., Moore, I. K., … Brown, A. L. (2022). Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance. Pediatric Blood & Cancer, 69(5), e29507. https://doi.org/10.1002/pbc.29507
Vasquez, Priscilla, Johanna Escalante, Kimberly P. Raghubar, Lisa S. Kahalley, Olga A. Taylor, Ida Ki Moore, Marilyn J. Hockenberry, Michael E. Scheurer, and Austin L. Brown. “Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.Pediatric Blood & Cancer 69, no. 5 (May 2022): e29507. https://doi.org/10.1002/pbc.29507.
Vasquez P, Escalante J, Raghubar KP, Kahalley LS, Taylor OA, Moore IK, et al. Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance. Pediatric blood & cancer. 2022 May;69(5):e29507.
Vasquez, Priscilla, et al. “Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.Pediatric Blood & Cancer, vol. 69, no. 5, May 2022, p. e29507. Epmc, doi:10.1002/pbc.29507.
Vasquez P, Escalante J, Raghubar KP, Kahalley LS, Taylor OA, Moore IK, Hockenberry MJ, Scheurer ME, Brown AL. Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance. Pediatric blood & cancer. 2022 May;69(5):e29507.
Journal cover image

Published In

Pediatric blood & cancer

DOI

EISSN

1545-5017

ISSN

1545-5009

Publication Date

May 2022

Volume

69

Issue

5

Start / End Page

e29507

Related Subject Headings

  • Sleep Wake Disorders
  • Sleep
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • Oncology & Carcinogenesis
  • Neuropsychological Tests
  • Male
  • Humans
  • Female
  • Fatigue
  • Executive Function